Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
NCT ID:
NCT05565820
Group ID:
EG000
Title:
Vamousse Spray 'n' Go
Description:
1. Recruitment Details:
Upon arrival at the clinic, lice-infested patients and their household members were screened for eligibility against the inclusion and exclusion criteria. Those in each household who passed the screening were assigned to one of the two treatment groups through a reversing alternation assignment procedure.
2. Type of Units Assigned:
Vamousse Spray 'n' Go Treatment Group: members of this group were treated at baseline and, if live lice were found, again at Day 7 subsequent to baseline with the Vamousse Spray 'n' Go product, which is a pediculicide for topical application, having as its active ingredient Natrum Muriaticum 2X (HPUS).
3. Periods:
A. Baseline to Day 7 Assessment 1) Completed 41 of the 43 subjects in this group completed this period. 2) Not Completed 2 subjects in this group dropped out of the study prior to the Day 7 assessment. B. Baseline to Day 14 Assessment 1) Completed 41 of the original 43 subjects in this group completed this period. 2) Not Completed 2 subjects in this group dropped out of the study prior to the 14th day after baseline.
4. Reasons Not Completed A. Reason Not Completed Type 1) Subject #16: Withdrawal by subject 2) Subject #17: Withdrawal by subject B. Reason Not Completed Data Withdrawal by subject: N = 2
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
43
Other Number Affected:
0
Other Number At Risk:
43
Study:
NCT05565820
Results Section:
NCT05565820
Adverse Events Module:
NCT05565820